DFC
EW icon

DB Fitzpatrick & Co’s Edwards Lifesciences EW Stock Holding History

DB Fitzpatrick & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
18,076
-292
-2% -$24.5K 1.32% 24
2026
Q1 		$1.47M Buy
18,368
+412
+2% +$34K 1.26% 22
2025
Q4 		$1.53M Sell
17,956
-181
-1% -$14.9K 1.36% 15
2025
Q3 		$1.41M Sell
18,137
-382
-2% -$29.8K 1.27% 21
2025
Q2 		$1.45M Buy
18,519
+67
+0.4% +$5K 1.29% 20
2025
Q1 		$1.34M Sell
18,452
-2,082
-10% -$149K 1.27% 18
2024
Q4 		$1.52M Sell
20,534
-472
-2% -$33K 1.4% 18
2024
Q3 		$1.39M Buy
21,006
+66
+0.3% +$4.79K 1.22% 31
2024
Q2 		$1.93M Sell
20,940
-154
-0.7% -$13.6K 1.79% 9
2024
Q1 		$2.02M Buy
21,094
+57
+0.3% +$4.79K 1.85% 6
2023
Q4 		$1.6M Buy
21,037
+3,213
+18% +$224K 1.54% 15
2023
Q3 		$1.23M Buy
17,824
+67
+0.4% +$5.38K 1.32% 22
2023
Q2 		$1.68M Sell
17,757
-911
-5% -$79.2K 1.77% 8
2023
Q1 		$1.54M Buy
18,668
+1,062
+6% +$83.5K 1.67% 14
2022
Q4 		$1.31M Buy
17,606
+5,196
+42% +$400K 1.5% 18
2022
Q3 		$1.02M Sell
12,410
-1,407
-10% -$135K 1.25% 29
2022
Q2 		$1.31M Buy
13,817
+527
+4% +$54.6K 1.45% 21
2022
Q1 		$1.56M Buy
13,290
+300
+2% +$33.7K 1.56% 18
2021
Q4 		$1.68M Buy
+12,990
New +$1.52M 1.57% 14

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

DB Fitzpatrick & Co's EW Position: Q2 2026 in Review

DB Fitzpatrick & Co reduced its Edwards Lifesciences (EW) stake by 1.6% in Q2 2026, selling an estimated $24.5K and leaving 18,076 shares worth $1.64M. The position accounts for 1.32% of the portfolio, ranked #24.

DB Fitzpatrick & Co first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.02M in Q1 2024. 663 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • DB Fitzpatrick & Co held 18,076 shares of Edwards Lifesciences worth $1.64M as of Q2 2026.
  • DB Fitzpatrick & Co sold 292 Edwards Lifesciences shares in Q2 2026, an estimated $24.5K.
  • Edwards Lifesciences made up 1.32% of DB Fitzpatrick & Co's portfolio in Q2 2026, its #24 holding.
  • DB Fitzpatrick & Co first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • DB Fitzpatrick & Co's Edwards Lifesciences position peaked at $2.02M in Q1 2024.
  • 663 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on DB Fitzpatrick & Co's 13F filing for Q2 2026, filed 15 Jul 2026.